Skip to main content
Mobile menu expand icon
Menu
Close
About Gimv
Investment platforms
Portfolio
Team
Sustainability
News
Investors
en
nl
fr
de
Search
About Gimv
Investment platforms
Portfolio
Team
Sustainability
News
Investors
Working at/with Gimv
Contact
Latest news Latest news Latest news
Latest news
Filter news
Authored on
*
(Optional)
Year
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Category
*
(Optional)
Category
Corporate
Portfolio
Investment platform
*
(Optional)
Investment platform
Consumer
Healthcare
Life Sciences
Smart Industries
Sustainable Cities
Apply
Show all
Portfolio
Imcheck Therapeutics raises USD 53 million, Gimv increases its investment in the immuno-oncology space
04/12/2019 - 06:45
Portfolio
Backed by Gimv, French Groupe Claire acquires Ijinus and reinforces its products pole for water systems equipment and solutions
27/11/2019 - 10:27
Corporate
Further growth and continuing strong portfolio results
21/11/2019 - 07:00
Portfolio
GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury
29/10/2019 - 15:43
Portfolio
Eric de Montgolfier appointed as CEO of Invest Europe
14/10/2019 - 08:00
Portfolio
One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy
09/09/2019 - 16:50
Portfolio
Equipe Zorgbedrijven intends to take over Heuvelrug Eye Clinic
09/09/2019 - 13:46
Portfolio
iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment
05/09/2019 - 08:00
Portfolio
AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.
30/07/2019 - 08:00
Portfolio
Gimv sells stake in thinkstep AG, the Stuttgart-based specialist in sustainability software.
30/07/2019 - 07:45
Portfolio
Gimv exits Legallais, ironmongery distributor for building professionals in France.
30/07/2019 - 07:30
Portfolio
Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development
25/07/2019 - 08:00
Pagination
See more news
Do you want to stay updated about Gimv news?
Subscribe to our press releases
Contact information
Investor Relations Investor Relations Investor Relations
Investor Relations
Do you have any questions or require more information? Please contact us.
Contact us